A practical reference on Heptapeptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-03-31. Anything still debated is marked as such rather than presented as settled.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Analogue of alpha-melanocyte-stimulating hormone |
| Common synonyms | MT-II; melanotan 2 | No internationally accepted non-proprietary name |
| Typical presentation | Lyophilised powder in a sealed vial | Often supplied alongside a separate diluent |
| Regulatory status | Unapproved therapeutic substance | Customs seizure reported in several jurisdictions |
| Reported route in use | Subcutaneous injection | Self-administered outside clinical settings |
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
It is a flexible tool for creating ROC graphs, sensitivity/specificity curves, area under curve and precision/recall curve. The parametrization can be visualized by coloring the curve according to cutoff. WebCDK: A web interface for the CDK library which is used for predicting descriptors of chemicals. Pharmacokinetics: This data analysis determines the relationship between the dosing regimen and the body's exposure to the drug as measured by the drug's nonlinear concentration time curve. It includes a function to calculate area under this curve. It also includes functions for half-life estimation for a biexponential model, and a two phase linear regression.
In July 1974, Fripp, Bruford, and Wetton began recording Red. Before recording began, Fripp, now increasingly disillusioned with the music industry, turned his attention to the works of English mystic John G. Bennett and had a spiritual experience in which "the top of my head blew off". Most of the album had been developed during live improvisations before Fripp "withdrew his opinion", leaving his bandmates to direct the sessions. The album contains one live track, "Providence", recorded on 30 June 1974 in Providence, Rhode Island with Cross on violin. Several guest musicians, including former members Ian McDonald and Mel Collins on saxophones, contributed to the album. Released on 6 October 1974, Red went to No. 45 in the UK and No. 66 in the US. AllMusic later called it "an impressive achievement" for a group about to disband, with "intensely dynamic" musical chemistry between the band members. Two months before the release of Red, King Crimson's future looked bright, with talks regarding the possibility of McDonald rejoining the group. However, Fripp wished not to tour as he felt increasingly disenchanted by the group and the music industry. He also felt the world was going to drastically change by 1981 and that he had to prepare for it. Despite a band meeting while touring the US in which Fripp expressed a desire to end the band, the group did not formally disband until 25 September 1974; the following month Fripp announced in an interview with Trouser Press magazine that King Crimson had "ceased to exist" and was "completely over for ever and ever".
Through the centuries, a variety of techniques for processing tea, and a number of different forms of tea, were developed. During the Han and Six Dynasties, tea was steamed and pounded, shaped into cake form, slowly dried over low fire, and suspended to air dry. Chunks of tea were then boiled to drink, flavoured with orange peels, jujube, mint, ginger or scallion. Tea was similarly prepared in cake form during the Tang dynasty, but Lu Yu disparaged the use of various condiments to flavour the tea apart from salt. By the Song dynasty, loose-leaf tea was developed and became common. During the Yuan and Ming dynasties, unoxidized tea leaves were first stirred in a hot dry pan, then rolled and air-dried, a process that stops the oxidation process that would have turned the leaves dark, thereby allowing tea to remain green. In the 15th century, oolong tea, in which the leaves are allowed to partially oxidize before being heated in the pan, was developed. Western tastes, however, favoured the fully oxidized black tea, and the leaves were allowed to oxidize further. Yellow tea was an accidental discovery in the production of green tea during the Ming dynasty, when apparently careless practices allowed the leaves to turn yellow, which yielded a different flavour.
Sources: en.wikipedia.org
Another possible example is the Second Congo War (1998–2003) even though it was only waged on one continent. It involved nine nations and led to ongoing low-intensity warfare despite official peace and the first democratic elections in 2006. It has been referred to as "Africa's World War". Similarly, other historians suggest even earlier conflicts to be world wars. For example, Russian ethnologist L. N. Gumilyov called the Byzantine–Sasanian War of 602–628 "the World War of the 7th century" because it evolved into a war between the fourfold informal alliance of the Chinese Empire, the Western Turkic Khaganate, the Khazars, and the Byzantine Empire against a triple union of the Sasanian Empire, the Avars, and the Eastern Turkic Khaganate, with proxy conflicts in Afro-Eurasia (like the Aksumite–Persian wars) and across the Old World.
== Fragile states == The Fragile States Index 2019, compiled by the NGO, Fund for Peace, ranked Thailand 77th in the world for fragility (178=least fragile; 1=most fragile). Finland topped the ranking; Yemen was at the bottom. Other ASEAN nations were ranked: Singapore, 162; Brunei, 124; Malaysia, 119; Vietnam, 109; Indonesia, 93; Laos, 62; Cambodia, 54; Philippines, 50; Myanmar, 22.
Skin cancer. The most common cause (etiology) for a nasal reconstruction is skin cancer, especially the lesions to the nose of melanoma and basal-cell carcinoma. This oncologic epidemiology occurs more readily among the aged and people who reside in very sunny geographic areas; although every type of skin is susceptible to skin cancer, white-skin is most epidemiologically prone to developing skin cancer. Furthermore, regarding plastic surgical scars, the age of the patient is a notable factor in the timely, post-surgical healing of a skin cancer defect (lesion); in terms of scarrification, the very elastic skin of young people has a greater regenerative propensity for producing scars that are thicker (stronger) and more noticeable. Therefore, in young patients, the strategic placement (hiding) of the rhinoplastic scars is a greater aesthetic consideration than in elder patients; whose less elastic skin produces scars that are narrower and less noticeable. Traumatic nasal defect. Although trauma is a less common rhinoplastic occurrence, a nasal defect or deformity caused by blunt trauma (impact), penetrating trauma (piercing), and blast trauma (blunt and penetrating) requires a surgical reconstruction that abides the conservational principles of plastic surgery, as in the corrections of cancerous lesions. Congenital deformities. The unique plastic properties of the bone, cartilage, and skin of patients' affected by congenital defects, and associated anomalies, are considered separately.
Sources: en.wikipedia.org
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.
It was developed in the 1980s by researchers investigating analogues of alpha-melanocyte-stimulating hormone for pigmentation and related endpoints. Early work included small human studies during the 1990s. Development did not progress to licensing, and the compound remained a research and grey-market item.
Peptides are prone to truncation, oxidation and aggregation during synthesis and handling. Without independent testing, a buyer cannot confirm the identity or the content of a vial. Analytical surveys of unapproved peptide products have repeatedly found discrepancies between label claims and measured composition.
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.